Baronsmead/Eden

[UncleEbenezer]

ISTR on TMF, someone (tolmers?) flagged up Baronsmead's investment in Eden Research as ... dubious.

Now From MrC's observations elsewhere on Lemonfool:

Eden Research (EDEN) "has received authorisation in France for its first product, 3AEY, for use in the prevention and treatment of botrytis in table and wine grapes." And for those who didn't know "France is one of the leading wine producers in the world."

Make of that what you will, but on the face of it that looks like a constructive use of (VCT) funding. Though it begs the question, what does "authorisation in France" - as opposed to at EU/single market level - actually mean?

[Kidman]

Eden announced on 11 February 2016 that 3AEY had received authorisation in Italy where it will be sold as 3LOGY.
They also mentioned in that news release that "3AEY has already been authorised for sale in Kenya, Malta, Greece and Bulgaria."

I suspect that a product needs to be authorised in one EU country first but then such approval needs to be passported to each other EU country individually, and that takes time!